Key Takeaways
- Artemis II launched April 1 — first humans beyond low Earth orbit in 54 years
- WTI crude up 37% to $112/barrel — shipping and fuel costs directly hitting consumers
- Liberation Day tariffs at 1 year: S&P +16% but 89K manufacturing jobs lost — divided legacy
- Foundayo (oral GLP-1) at $149/month could reshape the entire weight loss market
- 48 new trend pages — Iran-US conflict most covered topic with 6 pages
The 5 Biggest Stories of the Week
Artemis II: First Crewed Moon Mission in 54 Years
NASA launched the Orion capsule with 4 astronauts on April 1 from Kennedy Space Center. The crew is currently in transit and will perform a lunar flyby on Monday, April 6. This marks the first time humans have traveled beyond low Earth orbit since Apollo 17 in December 1972.
Read full coverage →Iran-US Conflict Enters Week 6: Oil Hits $112/Barrel
Crude oil surged to $111-112/barrel as the conflict intensified. A US F-15 was shot down over the Persian Gulf. Kuwait and Qatar refineries sustained damage from Iranian-backed attacks. Trump's Hormuz Strait ultimatum expires April 6 with no resolution in sight.
Trump Fires Attorney General Pam Bondi
President Trump dismissed AG Pam Bondi and named Todd Blanche as acting Attorney General. Former Rep. Lee Zeldin is the frontrunner for permanent replacement. The Pentagon simultaneously purged several Army generals in the latest military leadership shakeup.
Read full coverage →Liberation Day Tariffs: 1-Year Anniversary Report Card
The S&P 500 gained 16% since the tariffs were imposed, but 89,000 manufacturing jobs were lost. The Supreme Court ruled $166 billion in refunds are owed to importers. The economic legacy remains deeply divided along partisan lines.
Foundayo: Eli Lilly GLP-1 Pill Gets Record-Fast FDA Approval
The FDA approved Eli Lilly's oral GLP-1 weight loss drug Foundayo in a record 50 days. Priced at $149/month with no food restrictions, it removes major barriers to GLP-1 access. Analysts project it could reach $10 billion in annual sales by 2028.
Other Notable Stories
Week 15 by the Numbers
Coverage by Category
What to Watch Next Week
This Week in Context
Week 15 marked one of the most diverse weeks of 2026, with events spanning from deep space to Middle Eastern geopolitics. NASA's Artemis II launch brought a rare moment of collective wonder at a time when the world is grappling with surging oil prices and military confrontation in the Persian Gulf.
On the economic front, the Liberation Day tariffs 1-year anniversary painted a contradictory picture: stock markets up but manufacturing employment down. March's +178,000 jobs report was not enough for the Fed to change its year-long rate freeze. Meanwhile, the FDA approval of Foundayo may be the most consequential health event of the year — the first affordable oral GLP-1 weight loss drug.
In domestic US politics, Trump's firing of the Attorney General and purging of Army generals continues the consolidation of executive power. With the proposed $1.5 trillion defense budget — the largest since World War II — the militarization trajectory becomes increasingly clear.
ZestLab analysis: Week 15 reveals a 2026 that is simultaneously ambitious in exploration (Artemis II) and deeply fractured (tariffs, war, politics). The biggest question for next week: whether the April 6 Hormuz deadline escalates or de-escalates the conflict.
Browse all trend articles at ZestLab Trends, or explore free tools at ZestLab Tools.